Haemacure Corporation

Industry:	Medical Devices & Equipment
Revenues:	$6 Million
Employees:	35

Description

Haemacure Corporation is a Canada-based company that specializes in developing bio-surgical products and human therapeutic proteins for commercialization. The Company’s principal product candidate, Hemaseel HMN, is a human-derived fibrin sealant in late-stage clinical development. Its second product candidate is a hemostat consisting of human thrombin, a component of its fibrin sealant. Haemacure Corporation’s product candidates are derived from human plasma. The Company also sells fibrin sealant delivery devices that are Food and Drug Administration (FDA) approved. Haemacure Corporation’s product development activities focus on surgical hemostats, combinations with biomaterials and drug delivery in select therapeutic areas.

Products & Services

biological adhesives, surgical devices, human therapeutic proteins

View More Statistics

Site Statistics

Monthly Unique Visitors:	741
Site Rank:	1,413,422
Trust Rating:	Neutral
Stats by

News Archive

Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results. PR Newswire; 9/14/2009 ...Sept. 14 /PRNewswire-FirstCall/ -- Haemacure Corporation (TSX : HAE) reported today...quarter ended July 31. Current Activities Haemacure and Angiotech Pharmaceuticals, Inc...distribution and supply rights for Haemacure's all-human fibrin sealant and thrombin... ...more

Haemacure announces its presentation at the Rodman Renshaw 11th Annual Healthcare Conference. PR Newswire; 9/8/2009 ...MONTREAL, Sept. 8 /PRNewswire-FirstCall/ -- Haemacure Corporation (TSX:HAE), a specialty bio-therapeutics...minutes prior to start time for instructions. About Haemacure Haemacure Corporation is a specialty biotherapeutics company... ...more

Canadian firms Angiotech, Haemacure agree to collaborate.(INDUSTRY NEWS) Biomedical Materials; 7/1/2009 Angiotech Pharmaceuticals Inc and Haemacure Corp have entered into a strategic collaboration...distribution and supply rights related to Haemacure's all-human fibrin sealant and thrombin...up to an additional US$1 million to Haemacure from time to time, in multiple drawdowns... ...more